fda glp-1 warning news november 2025 Drugs: Pulse Survey (U.S.) Myths & Facts: GLP-1 Drugs

While most are approved for the management of type 2 diabetes, some formulations, such as semaglutide (Wegovy) and tirzepatide (Zepbound), have also been approved for chronic weight management in adults with obesity or overweight

Examples of synthetic GLP-1 are Semaglutide (ozempic, wegovy) which last 1 week, Liraglutide (Victoza, Saxenda) which last 24 hours, Tirzepatide (Mounjaro, Zepbound) which last 1 week and also targets GIP, and finally Exenatide (Byetta, Bydurette) which can last hours to a day

10.3892/etm.2016.3081 Exp Ther Med

It exhibits agonist activity for GIP, glucagon, and GLP-1 receptors

Once per week, done